In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.
about
Delivery of host cell-directed therapeutics for intracellular pathogen clearanceFuture Prospects for Scaffolding Methods and Biomaterials in Skin Tissue Engineering: A ReviewMultizone paper platform for 3D cell culturesNon-invasive and in situ characterization of the degradation of biomaterial scaffolds by volumetric photoacoustic microscopyThree-dimensional porous biodegradable polymeric scaffolds fabricated with biodegradable hydrogel porogens.Effect of pore structure of macroporous poly(lactide-co-glycolide) scaffolds on the in vivo enrichment of dendritic cells.Organic thin-film transistors fabricated on resorbable biomaterial substrates.Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.Development of intrinsically photoluminescent and photostable polylactonesIn vivo biodegradation and biocompatibility of PEG/sebacic acid-based hydrogels using a cage implant systemSynthetic small intestinal scaffolds for improved studies of intestinal differentiation.Rapid vaccination using an acetalated dextran microparticulate subunit vaccine confers protection against triplicate challenge by bacillus anthracis.Mammalian cell survival and processing in supercritical CO(2)Next generation of electrosprayed fibers for tissue regeneration.Electrospun poly(L-lactide) fiber with ginsenoside rg3 for inhibiting scar hyperplasia of skin.Biphasic calcium phosphate loading on polycaprolactone/poly(lacto-co-glycolic acid) membranes for improved tensile strength, in vitro biocompatibility, and in vivo tissue regeneration.Cell-friendly inverse opal-like hydrogels for a spatially separated co-culture systemFounder's award to Antonios G. Mikos, Ph.D., 2011 Society for Biomaterials annual meeting and exposition, Orlando, Florida, April 13-16, 2011: Bones to biomaterials and back again--20 years of taking cues from nature to engineer synthetic polymer scEffects of designed PLLA and 50:50 PLGA scaffold architectures on bone formation in vivo.Osteoblast growth and bone-healing response to three-dimensional poly(ε-caprolactone fumarate) scaffolds.Evaluating changes in structure and cytotoxicity during in vitro degradation of three-dimensional printed scaffolds.Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected miceOsteoinductive Effects of Free and Immobilized Bone Forming Peptide-1 on Human Adipose-Derived Stem CellsEffect of rapamycin on immunity induced by vector-mediated dystrophin expression in mdx skeletal muscleA biodegradable perivascular wrap for controlled, local and directed drug delivery.Engineering nanomedicines using stimuli-responsive biomaterials.Engineering the lipid layer of lipid-PLGA hybrid nanoparticles for enhanced in vitro cellular uptake and improved stability.Gene delivery from polymer scaffolds for tissue engineering.Imaging of poly(α-hydroxy-ester) scaffolds with X-ray phase-contrast microcomputed tomography.Advancing biomaterials of human origin for tissue engineering.Fluorinated methacrylamide chitosan hydrogels enhance collagen synthesis in wound healing through increased oxygen availability.Controlled delivery of mesenchymal stem cells and growth factors using a nanofiber scaffold for tendon repair.In vitro and in vivo study of sustained nitric oxide release coating using diazeniumdiolate-oped poly(vinyl chloride) matrix with poly(lactide-co-glycolide) additive.Synchrotron-Based in Situ Characterization of the Scaffold Mass Loss from Erosion Degradation.2007 AIChE Alpha Chi Sigma Award: From Material to Tissue: Biomaterial Development, Scaffold Fabrication, and Tissue Engineering.Local sustained delivery of acetylsalicylic acid via hybrid stent with biodegradable nanofibers reduces adhesion of blood cells and promotes reendothelialization of the denuded artery.Poly(lactide-co-glycolide) porous scaffolds for tissue engineering and regenerative medicine.Targeting monocyte and macrophage subpopulations for immunotherapy: a patent review (2009 - 2013).Current strategies in multiphasic scaffold design for osteochondral tissue engineering: A review.A quicker degradation rate is yielded by a novel kind of transgenic silk fibroin consisting of shortened silk fibroin heavy chains fused with matrix metalloproteinase cleavage sites.
P2860
Q27006858-A49C71A0-C67F-480E-8AE8-A0AD2031D79EQ28077861-4D16AA53-22EE-48CA-A07F-3D264E111065Q28740410-D96AF91D-C6A9-45D2-BC53-BDF24CBA3F81Q30421464-88610738-D2FF-4BC9-98C9-1A0BD8BF0597Q33643864-8714DAFA-9107-4766-AA3F-F32B2EF90C35Q33752781-1C59E01D-9429-4D12-9A1E-9AD082AD8303Q33846054-FBDB2681-0BE7-4230-9B2D-7826C9C604A7Q33902253-33B1D49C-9BF3-4D0F-9134-FD1B5C236335Q33934257-436AF3B2-BB17-4D7B-93F5-0A6D82EA5189Q34086404-A70B916B-19AA-40E4-B2E6-563B10F9522AQ34520863-537EC3BA-298C-4057-8847-85FBB5BA5FBDQ34564854-51AAD283-781C-4E1A-9C29-E018BB28FEA7Q34624569-B63249F5-C252-422D-B8EA-3B7D12A3BECDQ34707891-C2EE01AA-FDA2-4E39-A4AB-3EC41AE31CD2Q34851005-A8652620-F547-48ED-973B-2949A01B9728Q34981130-B5A2E315-9B5C-4752-A730-2FB5FC100D59Q35053930-2485276A-747C-4484-B356-9B0181679861Q35168811-C2485ED5-9D38-4570-829C-B0CB134460F4Q35200795-01B9E553-8A22-49D5-ACEB-05C434BB3F8DQ35541674-2BDF5E2C-5A5C-401D-8BFB-CE0ED96E4549Q35589837-C83EA455-3680-4AB4-B36C-89E18FCDD6E8Q35758804-E3FB38F0-A255-4E18-9479-132B922F375BQ35940698-42B3AA41-FE56-4909-BAC0-446EB7652DAAQ35943638-D351BDF6-154A-478C-B0FE-1C996189926EQ36044303-53FE8C48-BB28-4BF9-98D4-611E807F5A98Q36174884-4308E1F0-4F6C-4C59-89DF-E5340578284CQ36289194-AE00E1CE-8E5C-469B-85C0-04785596CB38Q36314939-E043ADCD-6BB4-4935-A508-B2D6D2CEF9D5Q36353188-48D2EA57-0E92-484B-A0FE-7C4CD584E0BAQ36729634-2FE1E9A1-0789-4EC8-8E34-2DC241DBC842Q36840072-4B3DF406-1FD8-4868-8029-A0B61BC8FD4EQ36844211-A09F8C59-B566-4DD5-B39A-CCAE7EEAB71BQ37058223-839C7A93-3522-4DDA-8334-F16933AE53C5Q37293825-5552CE0A-39E8-4397-96B1-1BBB93685679Q37345739-F94EDDA4-1E27-4C7F-B86D-5E370616065FQ37464405-923C0575-279C-4783-B77D-8137E7F18764Q38112429-D02ECCE1-1B48-4550-8072-AD8E4CF7BF52Q38207732-7DA50AFD-6B81-469F-8F71-C8EE6DD71FE9Q38262783-545B5B00-7993-4928-9FE8-6B93BEDE398BQ38307320-B1346B65-81F8-4B66-8FB1-89EBB45FAFF4
P2860
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
In vitro and in vivo degradation of porous poly
@nl
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.
@en
type
label
In vitro and in vivo degradation of porous poly
@nl
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.
@en
prefLabel
In vitro and in vivo degradation of porous poly
@nl
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.
@en
P2093
P1433
P1476
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.
@en
P2093
Vacanti JP
P304
P356
10.1016/S0142-9612(00)00047-8
P577
2000-09-01T00:00:00Z